Hikma Pharmaceuticals PLC (LSE:HIK) - Share price - Overview

Stock Report

Hikma Pharmaceuticals PLC HIK

Last Price
GBX1,516.00

Day Change
-76.00|-4.77%

As of 27/06/2017
17:05:57 BST | GBX
Minimum 15 Minutes Delay.

Last Close1,592.00p
Day Range1,513.67 - 1,577.20
Mkt Cap3.83Bil
52-Wk Range1,513.67 - 2,703.00
Yield %1.51
ISINGB00B0LCW083
Volume127,571
P/E23.95
P/S2.45
P/CF19.78

Share Price

Total Returns 26/06/2017

 Chg (%)  
More ...
Hikma Pharmaceuticals PLC-5.87 
FTSE 100 TR GBP-1.05
 
Financials
201420152016
More ...
Income Statement
Turnover906.03942.521,444.56
Operating Profit244.61249.38223.72
Net Profit171.59166.25117.05
Reported EPS84.5882.0849.04
Balance Sheet
Current Assets650.84922.721,171.85
Non Current Assets795.39839.272,359.08
Total Assets1,446.231,761.993,530.93
Current Liabilities540.33401.66742.93
Total Liabilities664.97844.701,579.73
Total Equity781.26917.291,951.20
Cash Flow
Operating Cash Flow306.67272.94273.36
Net Change in Cash68.76183.92-283.73
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017255.6385.2534.7018.680.5426.131.64
2018333.83103.2921.1615.410.7327.541.73

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
30/05/2017Transfer inMr. Mazen Darwazah0.0038,0880.00
30/05/2017Transfer inMr. Said Darwazah0.0052,1640.00
15/05/2017Transfer inMr. Mazen Darwazah0.0030,0000.00
15/05/2017Transfer inMr. Said Darwazah0.0041,0000.00

Company Profile

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

120 of 1845 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(19/05/2017) "We expect full year group revenue to be in the range of $2.00 to $2.10 billion in constant currency in 2017"

Next Event 17/08/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)16.9515.4816.73
Div Yld (E)1.683.534.11
PEG (E)0.620.471.01
ROCE17.70190.3017.49
Op Mrgn15.44-3.152.90
EPS Grwth27.1744.4131.85
Dividends
PreviousLatest
More ...
Record Date02/09/1607/04/17
Ex-Div01/09/1606/04/17
Paid30/09/1625/05/17
Amnt8.4517.91

Broker Sentiment

Strong Buy0
Buy2
Hold2
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chairman & Chief Executive OfficerMr. Said Darwazah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.